학술논문
Prophylaxis with tixagevimab/cilgavimab is associated with lower COVID-19 incidence and severity in patients with autoimmune diseases
Document Type
Article
Author
Source
In: Rheumatology (United Kingdom) . (Rheumatology (United Kingdom), 1 June 2024, 63(6):1632-1638)
Subject
Language
English
ISSN
14620332
14620324
14620324